BioSpace News Archive

Biotech Beach

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings

Tarsus Pharmaceuticals, Inc. today announced that the results from the Saturn-2 pivotal Phase 3 trial of TP-03 (lotilaner ophthalmic solution, 0.25%) in Demodex blepharitis patients will be presented at the upcoming World Cornea Congress (WCC) VIII and the American Academy of Ophthalmology (AAO) 2022 Annual Meetings in Chicago, Illinois.

September 27, 2022
·
6 min read
Business

AustinPx Names Elizabeth Hickman Chief Business Officer

AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing organization, announced the appointment of Elizabeth Hickman as Chief Business Officer.

September 27, 2022
·
3 min read
Pharm Country

Todos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest™

Todos Medical, Ltd. today announced that its majority-owned joint venture 3CL Pharma Ltd. received a Notice of Allowance issued by the USPTO for the Company’s proprietary SARS-CoV-2.

September 27, 2022
·
8 min read
Ambulero Receives Positive Pre-IND Response from FDA for AMB-301 Treatment of Rare Vascular Disease

Ambulero, Inc. announces it received a positive response from a Type B Pre-IND meeting with the FDA to develop AMB-301 as a treatment for a rare vascular condition called Buerger’s Disease.

September 27, 2022
·
2 min read
Protein Expression Market Size, Share, Trends, Growth, Forecast 2022-2030

The global Protein Expression market size is expected to hit around US$ 13.0 billion by 2030, according to a new report by Vision Research Reports.

September 27, 2022
·
8 min read
Increasing Prevalence Of The Genetic Disorder Across The Globe Is Expected To Drive Alagille Syndrome Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Alagille Syndrome Market – Forecast to 2030,’ thoroughly examines the Alagille Syndrome industry to provide essential data & information for the targeted readers.

September 27, 2022
·
6 min read
Increasing Incidence Rate Of Pressure Ulcer Is Expected To Drive Pressure Ulcer Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Pressure Ulcer Market – Forecast to 2030,’ thoroughly examines the Pressure Ulcer industry to provide essential data & information for the targeted readers.

September 27, 2022
·
6 min read
Lipocine to Participate in the Cantor Neurology & Psychiatric Conference

Lipocine Inc. announced today that it will participate in the Cantor Neurology & Psychiatric Conference (October 6-7) in San Francisco.

September 27, 2022
·
3 min read
FDA

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

IHEEZO™ Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14 Years.

September 27, 2022
·
8 min read
Policy

REVA Medical Announces Initiation of Enrollment in the MOTIV IDE Clincial Trial

REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in both the U.S. and Europe.

September 27, 2022
·
5 min read